Abstract - European Medical Journal

Continue

Abstracts

Neurology
2 Mins
10 Aug 2017

Longitudinal Assessment of Cognitive Functions and Quality of Life in Long Surviving Patients with Glioblastoma

Long surviving glioblastomas (GBM) are defined as when cases have an overall survival of >5 years from the diagnosis of GBM, accounting for 5% of all…
Neurology
1 Mins
10 Aug 2017

Glioneuronal Tumours

Glioneuronal tumours are histologically mixed neuronal and glial tumours, according to the World Health Organization (WHO) Classification of 2016.
Hematology
2 Mins
8 Aug 2017

The Simm Study: Survey of Integrative Medicine in Myeloproliferative Neoplasms

In patients with myeloproliferative neoplasms (MPN), including essential thrombocytosis (ET), polycythaemia vera (PV), and myelofibrosis (MF), symptoms…
Hematology
2 Mins
8 Aug 2017

Targeting Nanoparticles to Chronic Lymphocytic Leukaemia: Exploiting the Properties of CXCR4

A key aim of modern cancer medicine is the improvement of treatment efficacy and overall patient health using targeted therapies.
Hematology
2 Mins
8 Aug 2017

Haemoglobin Level and White Cell Count in Patients Clinically Suspected to have Essential Thrombocythaemia may help in Predicting Early Primary Myelofibrosis or Unclassifiable Myeloproliferative Neoplasm

Accurate diagnosis of essential thrombocythaemia (ET) and differentiation between ET and pre-fibrotic stages of primary myelofibrosis (PMF) can be…
Hematology
1 Mins
8 Aug 2017

Front-Line Vascular Access Devices in Peripherally Inserted Acute Leukaemias: Central Catheter Versus Traditional Central Venous Catheter: A Phase IV Randomised Trial

For high-risk haematological patients, in particular those with acute leukaemia, there is limited information on the use of peripherally inserted…
Hematology
1 Mins
8 Aug 2017

Oral Rigosertib Combined With Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukaemia: Effects in Treatment Naïve and Relapsed/ Refractory Patients

Azacitidine is the standard of care for higher risk myelodysplastic syndromes (MDS); however, only approximately 50% of patients respond, and those…
Hematology
2 Mins
8 Aug 2017

Minimal Residual Disease Monitoring by Digital PCR for JAK2V617F Detection in Patients with Myelofibrosis or Acute Myeloid Leukaemia Secondary to Myelofibrosis after Allogeneic Stem Cell Transplantation

Myelofibrosis (MF) is one of the BCR-ABL1-negative chronic myeloproliferative neoplasms (MPNs), characterised by clonal expansion of abnormal…